Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,137 | 958 | 92.3% |
| Debt forgiveness | $1,250 | 1 | 6.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 0.7% |
| Education | $55.39 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,887 | 108 | $0 (2024) |
| Amgen Inc. | $1,590 | 83 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,537 | 83 | $0 (2024) |
| PhotoniCare Inc | $1,274 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,226 | 78 | $0 (2024) |
| Novo Nordisk Inc | $1,180 | 71 | $0 (2024) |
| PFIZER INC. | $858.03 | 55 | $0 (2024) |
| Lilly USA, LLC | $508.37 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $481.70 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $408.24 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,168 | 122 | PhotoniCare Inc ($1,250) |
| 2023 | $1,817 | 95 | ABBVIE INC. ($393.44) |
| 2022 | $1,980 | 111 | ABBVIE INC. ($478.60) |
| 2021 | $2,002 | 129 | AbbVie Inc. ($302.25) |
| 2020 | $1,847 | 89 | AstraZeneca Pharmaceuticals LP ($231.15) |
| 2019 | $1,968 | 131 | Janssen Pharmaceuticals, Inc ($216.14) |
| 2018 | $2,657 | 156 | GlaxoSmithKline, LLC. ($389.08) |
| 2017 | $2,129 | 137 | AstraZeneca Pharmaceuticals LP ($317.97) |
All Payment Transactions
970 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PhotoniCare Inc | OtoSight Middle Ear Scope (Device) | Debt forgiveness | In-kind items and services | $1,250.00 | General |
| Category: Diagnostic Imaging | ||||||
| 12/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Oncology | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $92.02 | General |
| Category: Neurology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Opioid Use Disorder | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Biological | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: PAIN | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Analgesic | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $6.33 | General |
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Gastroenterology | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,711 | 3,531 | $579,767 | $218,967 |
| 2022 | 21 | 1,573 | 3,615 | $653,115 | $253,765 |
| 2021 | 17 | 1,301 | 4,451 | $650,732 | $265,763 |
| 2020 | 19 | 1,623 | 2,890 | $525,506 | $207,082 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 1,301 | $311,145 | $105,049 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 200 | 200 | $49,982 | $24,377 | 48.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 61 | 344 | $29,645 | $12,452 | 42.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 44 | 61 | $28,435 | $12,361 | 43.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 61 | 338 | $29,190 | $12,267 | 42.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 102 | $33,118 | $11,371 | 34.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 150 | 154 | $25,613 | $9,784 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 105 | $18,181 | $5,597 | 30.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 69 | 70 | $10,078 | $5,173 | 51.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 38 | 115 | $8,630 | $3,534 | 40.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 202 | 202 | $6,941 | $3,512 | 50.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 20 | $7,229 | $3,039 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 77 | 80 | $4,480 | $2,419 | 54.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,821 | $2,371 | 49.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 220 | 325 | $2,539 | $2,277 | 89.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $6,722 | $2,110 | 31.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 38 | 40 | $1,430 | $564.06 | 39.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 15 | 15 | $661.18 | $367.53 | 55.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 14 | $472.04 | $200.89 | 42.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $454.80 | $143.28 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 332 | 1,665 | $399,467 | $145,688 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 221 | 221 | $54,163 | $27,741 | 51.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 106 | 165 | $55,569 | $21,630 | 38.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 56 | 76 | $39,280 | $16,068 | 40.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 161 | 168 | $26,507 | $9,655 | 36.4% |
About Dr. Varesh Patel, DO
Dr. Varesh Patel, DO is a Family Medicine healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760461289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Varesh Patel, DO has received a total of $18,568 in payments from pharmaceutical and medical device companies, with $4,168 received in 2024. These payments were reported across 970 transactions from 94 companies. The most common payment nature is "Food and Beverage" ($17,137).
As a Medicare-enrolled provider, Patel has provided services to 6,208 Medicare beneficiaries, totaling 14,487 services with total Medicare billing of $945,577. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Orlando, FL
- Active Since 01/12/2006
- Last Updated 02/05/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760461289
Products in Payments
- OtoSight Middle Ear Scope (Device) $1,274
- FARXIGA (Drug) $924.27
- TRELEGY ELLIPTA (Drug) $899.80
- NURTEC ODT (Drug) $787.35
- MAVYRET (Drug) $571.92
- VRAYLAR (Drug) $514.92
- Repatha (Biological) $478.88
- Aimovig (Biological) $431.56
- Ozempic (Drug) $412.07
- Rybelsus (Drug) $350.79
- Mavyret (Drug) $308.31
- QULIPTA (Drug) $307.51
- UBRELVY (Drug) $293.18
- JARDIANCE (Drug) $277.39
- BREO (Drug) $261.14
- Lucemyra/Lofexidine (Drug) $257.49
- Vascepa (Drug) $255.82
- SUBLOCADE (Drug) $251.85
- JANUVIA (Drug) $235.28
- Prolia (Biological) $234.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Orlando
Dr. Richard Lapp, D.o, D.O
Family Medicine — Payments: $703,882
Dr. Humberto Cruz, D.o, D.O
Family Medicine — Payments: $372,338
Dr. Eva-Maria Heurich, D.o, D.O
Family Medicine — Payments: $216,011
Dr. Asim Rahman, Md, MD
Family Medicine — Payments: $176,516
Dr. Rafael Pinero, M.d, M.D
Family Medicine — Payments: $56,968
Esther Schumann, Md, MD
Family Medicine — Payments: $42,978